USA Far Ocean Group Inc. Issues Voluntary Nationwide Recall of X-Hero and Male Enhancer, Products Marketed as Dietary Supplements

Date of Recall
2011-03-28

Recall Details
- March 25, 2011 - USA Far Ocean Group Inc., 1609 W. Valley Blvd., #338, Alhambra, CA 91803, announced today that it is conducting a voluntary nationwide recall of the Company's two supplement products sold under the names X-Hero and Male Enhancer. The Company has been informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of X-Hero sample found the product contains sulfosildenafil, the analogue of the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making X-Hero an unapproved drug. In addition, FDA analysis of Male Enhancer sample found the product contains tadalafil, the active ingredient of an FDA-approved drug used to treat erectile dysfunction (ED), making Male Enhancer an unapproved drug.

FDA advised that both products pose a threat to consumers because they may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. According to the FDA, consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. FDA advises that ED is a common problem in men with these conditions, and they may seek products to enhance sexual performance. FDA advises that either sulfosidenafil or tadalafil may cause side effects, such as headaches and flushing.

These two products have been distributed nationwide via retail stores, internet sales and mail order. All of the following packages of X-Hero and Male Enhancer products are involved in this voluntary recall:

Product Package Size UPC Codes
X-Hero with English Label 10 capsules 689087070995
X-Hero with English Label 8 capsules 689076499255
X-Hero with Chinese/English Label 8 capsules 689076499255
X-Hero with English Label 1 capsule pack
None
Male Enhancer 60 capsule 982010061205
Consumers who have X-Hero or Male Enhancer in their possession should stop using it immediately and contact their physician if they experienced any problem that may be related to taking this product. Any adverse reactions or quality problems experienced with the use of any counterfeit products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
No illnesses have been reported to the Company to date in connection with this product.Consumers in possession of products should return any unused products to their immediate supplier for a direct refund. Customers with questions can call 909-839-3058 Monday through Sunday between 9 a.m. and 5 p.m. for further instructions or information with respect to the return and refund process.

Recall Comments

Leave a Comment
No comments have been posted.
Be the first to add a comment!